Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127001201 | 12700120 | 1 | I | 20160819 | 20160830 | 20160830 | EXP | BR-ELI_LILLY_AND_COMPANY-BR201608010434 | ELI LILLY AND CO | 0.00 | M | Y | 0.00000 | 20160830 | CN | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127001201 | 12700120 | 1 | PS | CIALIS | TADALAFIL | 1 | Unknown | 20 MG, UNKNOWN | Y | U | 21368 | 20 | MG | TABLET | |||||
127001201 | 12700120 | 2 | SS | CIALIS | TADALAFIL | 1 | 20 MG, PRN | Y | U | C583455 | 21368 | 20 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127001201 | 12700120 | 1 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127001201 | 12700120 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127001201 | 12700120 | Drug ineffective | |
127001201 | 12700120 | Haemorrhoids | |
127001201 | 12700120 | Intentional product misuse | |
127001201 | 12700120 | Suspected counterfeit product | |
127001201 | 12700120 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127001201 | 12700120 | 1 | 2011 | 0 | ||
127001201 | 12700120 | 2 | 20160710 | 0 |